Top compounds associated with response to CLCN4


Feature Type Standardized
Nominal ANOVA
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.073 0.08
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.061 0.08
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.063 0.08
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.057 0.08
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.08
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.062 0.08
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.066 0.08
mRNA BI-2536 GDSC1000 pan-cancer AAC -0.091 0.08
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.059 0.08
mRNA MLN4924 GDSC1000 pan-cancer AAC -0.068 0.08
Download CSV